Free Fatty Acid Sulfur Composite Biomaterials
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing free fatty acid (FFA)-based biomaterials suffer from poor mechanical properties and are susceptible to degradation and immune responses, limiting their effectiveness in medical devices and other applications.
Innovation Solution
The development of sulfur crosslinked FFA-based composites, where elemental sulfur (S8) is used to crosslink unsaturated FFAs through a thiol-ene-like reaction, enhancing mechanical stability and antimicrobial properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If free fatty acids are used as biomaterials, then biocompatibility is improved, but mechanical strength deteriorates
Solution Approach 1:
The patent combines free fatty acids with crosslinking agents (such as silanes, epoxies, or anhydrides) to create composite biomaterials. The FFA provides biocompatibility while the crosslinking agent forms a robust network structure that supplies mechanical strength, thus resolving the contradiction between softness and structural integrity.
Solution Approach 2:
The patent modifies the physical and chemical parameters of free fatty acids through controlled crosslinking reactions. By adjusting crosslinking density, molecular weight, and functional group composition, the material transitions from a soft, oil-like state to a mechanically robust gel or solid while preserving biocompatibility.
2Strength
If FFAs are crosslinked by oxidative crosslinking, then mechanical properties are improved, but susceptibility to digestion and inflammation increases
Solution Approach 1:
The patent extracts and eliminates the harmful oxidative crosslinking mechanism from the FFA modification process. Instead, it employs non-oxidative crosslinking methods (such as silane crosslinking or epoxy crosslinking) that form stable bonds without generating radicals or inflammatory byproducts, thus improving mechanics without compromising biocompatibility.
Solution Approach 2:
The patent converts the potential harm of FFA oxidation (which causes rancidity and inflammation) into a benefit by using controlled non-oxidative crosslinking. This approach stabilizes the FFA structure, preventing spontaneous oxidation while creating mechanically strong hydrogels with improved durability and reduced inflammatory response.
3Object-affected harmful factors
If FFA-based materials are used in medical devices, then immune response is reduced, but mechanical durability deteriorates
Solution Approach 1:
The patent creates composite FFA-based materials where the FFA matrix provides immune compatibility while embedded crosslinked networks or reinforced phases (such as nanocellulose, glass fibers, or metal oxides) provide enhanced mechanical durability and long-term stability in physiological environments.
4Quantity of substance
If animal-derived fats and oils are hydrolyzed to produce FFAs, then FFA-based biomaterials are obtained, but quality degradation and rancidification increase
Solution Approach 1:
The patent applies preliminary crosslinking treatment to FFA extracts from animal fats and oils before they can undergo spontaneous oxidation and rancidification. This pre-crosslinking stabilizes the FFA molecules, locking them into a durable network structure that resists degradation, thereby preserving quality while maximizing FFA utilization.
Solution Approach 2:
The patent converts the harmful effect of FFA instability and rancidification into a benefit by using controlled crosslinking reactions. The crosslinked structure prevents spontaneous oxidation, transforms volatile FFAs into stable gel networks, and improves overall compositional stability while maintaining the desired FFA functionality for biomaterial applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting FFA/S8 composites exhibit improved mechanical strength, thermal recyclability, and innate antimicrobial activity, reducing the risk of immune responses and infections in medical applications.
Implementation Method 1
elemental sulfur (S8) is used to crosslink unsaturated FFAs through a thiol-ene-like reaction
Implementation Method 2
which is capable of being repaired by thermal processes
Data Source
AI summary
An improved material, preferably a biomaterial, is provided which is the reaction product of S8 and a free fatty acid or free fatty acid-containing material, preferably in the presence of metal. The improved material can be made by a method comprising reacting S8 with a free fatty acid to obtain a FFA/S8 composite and shaping the FFA/S8 composite into a solid form. The solid form of said FFA/S8 is melted to form melted FFA/S8 and the melted FFA/S8 is optionally applied as a coating on a surface, used as an adjacent material to a surface or the FFA/S8 composite itself is shaped thereby forming a device and preferably a medical device.